Harter, P, Bidzinski, M, Colombo, N, Floquet, A, Rubio Perez, M J, Kim, J-W, Lheureux, S, Marth, C, Nyvang, G-B, Okamoto, A, Reuss, A, Scambia, G, Trillsch, F, Vardar, M A, Van Nieuwenhuysen, E, Lichfield, J, Rugman, P, Twumasi-Ankrah, P & Aghajanian, C 2019, ' DUO-O: A randomized phase Ill trial of durvalumab (durva) in combination with chemotherapy and bevacizumab (bev), followed by maintenance durva, bev and olaparib (olap), in newly diagnosed advanced ovarian cancer patients ', Journal of Clinical Oncology, vol. 37, no. 15 Supplement, TPS5598 . https://doi.org/10.1200/JCO.2019.37.15suppl.TPS5598